BSE filing, NSE: OMKARPH. Summary written from the filing by ALFA Finder's alert engine.
Omkar Pharmachem Ltd: key numbers
- Share price
- ₹6.57
- Market cap
- ₹6.63 Cr
- Revenue (annual)
- ₹0.46 Cr
- Net profit (annual)
- ₹0.12 Cr
- P/E (TTM)
- 77.8×Sector 34.1×
- Promoter holding
- 0.03%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Omkar Pharmachem Ltd
All →Omkar Pharmachem Annual General Meeting
Omkar Pharmachem Limited concluded its 31st Annual General Meeting on September 30, 2026. Shareholders transacted business including the adoption of financial statements and approval of material related party transactions.
Omkar Pharmachem Annual Report
Omkar Pharmachem Ltd has submitted its 31st Annual Report and Notice for the Annual General Meeting scheduled for September 30, 2026. The agenda includes approving audited accounts.
Omkar Pharmachem Annual General Meeting
Omkar Pharmachem Ltd has scheduled its 31st Annual General Meeting for September 30, 2026. Key agenda items include adopting financial statements and approving material related party transactions.
- Execution
- FY 2026-27
Omkar Pharmachem Board Meeting Outcome
Omkar Pharmachem Ltd has announced the outcome of its board meeting, including the schedule for its 31st Annual General Meeting and related party transactions approval.
Omkar Pharmachem Q1 FY27 Results: Net Profit ₹0 Cr
Omkar Pharmachem Ltd reported revenue from operations of ₹0.1 Cr (+0.0% YoY) and net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Omkar Pharmachem Board Meeting Date
Omkar Pharmachem will hold a board meeting on August 13, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.